The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Yuki Katagiri

Showing 1-20 of 24 articles
Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial
Miyazaki Y, Muramatsu T, Asano T, Katagiri Y, Sotomi Y, Nakatani S, Takahashi K, Kogame N, Higuchi Y, Ishikawa M, Kyono H, Yano M, Ozaki Y, Serruys P, Okamura T, Onuma Y
March 19, 2021 | 10.4244/EIJ-D-18-00902
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys P
February 19, 2021 | 10.4244/EIJ-D-18-01201
Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.
Katagiri Y, Torii R, Takahashi K, Tenekecioglu E, Asano T, Chichareon P, Tomaniak M, Piek J, Wykrzykowska J, Bullett N, Ahmed N, Al-Lamee K, Al-Lamee R, Leclerc G, Kitslaar P, Dijkstra J, Reiber J, Poon E, Bourantas C, Gijsen F, Serruys P, Onuma Y
June 12, 2020 | 10.4244/EIJ-D-18-01190
Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data
Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K, Windecker S, Kastrati A, Serruys P
March 20, 2020 | 10.4244/EIJ-D-18-01080
Coronary interventions
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial
Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek J, Wykrzykowska J, Asano T, Kogame N, Takahashi K, Chang C, de Winter R, Serruys P, Wijns W
February 7, 2020 | 10.4244/EIJ-D-18-00944
Coronary interventions
Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation
Katagiri Y, Serruys P, Tenekecioglu E, Asano T, Collet C, Miyazaki Y, Katsikis A, Piek J, Wykrzykowska J, Chevalier B, Mintz G, Stone G, Onuma Y
September 20, 2019 | 10.4244/EIJ-D-18-00422
Coronary interventions
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabaté M, Iqbal J, Wykrzykowska J, Piek J, Spitzer E, Jüni P, Hamm C, Steg P, Valgimigli M, Vranckx P, Windecker S, Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Coronary interventions
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial
Modolo R, Chichareon P, Kogame N, Asano T, Chang C, de Winter R, Kaul U, Zaman A, Spitzer E, Takahashi K, Katagiri Y, Soliman O, Van Es G-A, Morel M, Onuma Y, Serruys P
July 19, 2019 | 10.4244/EIJ-D-18-00499
Coronary interventions
Early strut protrusion and late neointima thickness in the Absorb bioresorbable scaffold: a serial wall shear stress analysis up to five years
Tenekecioglu E, Torii R, Katagiri Y, Asano T, Modolo R, Miyazaki Y, Chichareon P, Poon E, Gijsen F, Thondapu V, van Klaveren D, Jonker H, Ooi A, Barlis P, Collet C, Onuma Y, Bourantas C, Serruys P
July 19, 2019 | 10.4244/EIJ-D-18-00381
Coronary interventions
On-line three-dimensional OFDI guided PCI vs. angiography guided in bifurcation lesions: design and rationale of the randomized OPTIMUM trial
Miyazaki Y, Muramatsu T, Asano T, Katagiri Y, Sotomi Y, Nakatani S, Takahashi K, Kogame N, Higuchi Y, Ishikawa M, Kyono H, Yano M, Ozaki Y, Serruys P, Okamura T, Onuma Y
July 9, 2019 | 10.4244/EIJ-D-18-00902
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys P, Farooq V, Banning A, Escaned J, Wykrzykowska J, Piek J, Dudek D, Ochala A, Hildick-Smith D, Goicolea J, Iñiguez A, Buszman P, Modolo R, Katagiri Y, Kogame N, Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
Coronary interventions
How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials
Katagiri Y, Serruys P, Asano T, Miyazaki Y, Chichareon P, Modolo R, Takahashi K, Kogame N, Wykrzykowska J, Piek J, Onuma Y
May 20, 2019 | 10.4244/EIJ-D-18-00607
Coronary interventions
Serial comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polymer coated everolimus-eluting Xience stent: 6- and 24-month results of DESSOLVE III OCT sub-study
Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys P
May 7, 2019 | 10.4244/EIJ-D-18-01201
Coronary interventions
Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs
Onuma Y, Katagiri Y, Burzotta F, Holm N, Amabile N, Okamura T, Mintz G, Darremont O, Lassen J, Lefèvre T, Louvard Y, Stankovic G, Serruys P
February 7, 2019 | 10.4244/EIJ-D-18-00391
Coronary interventions
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial
Asano T, Jin Q, Katagiri Y, Kogame N, Takahashi K, Chang C, Chichareon P, Wang C, Shi B, Su X, Fu G, Wu Y, Zhou X, Yuan Z, Wykrzykowska J, Piek J, Serruys P, Onuma Y, Chen Y
December 20, 2018 | 10.4244/EIJ-D-18-00461
Coronary interventions
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y, Onuma Y, Asano T, Iñiguez A, Okkels Jensen L, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys P, Räber L, Sabaté M, Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
Coronary interventions
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y, Onuma Y, Asano T, Chichareon P, Collet C, Miyazaki Y, Piek J, Wykrzykowska J, Abizaid A, Ormiston J, Chevalier B, Serruys P
October 12, 2018 | 10.4244/EIJ-D-18-00301
STEMI
Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial
Sotomi Y, Onuma Y, Liu S, Asano T, Eggermont J, Katagiri Y, Cavalcante R, de Winter R, Wykrzykowska J, Brugaletta S, Räber L, Sabaté M, Windecker S, Dijkstra J, Serruys P
August 24, 2018 | 10.4244/EIJ-D-17-00884
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabaté M, Onuma Y, Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
Coronary interventions
Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial
Tijssen RY, Kraak R, Elias J, van Dongen I, Kalkman D, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek J, Henriques J, de Winter R, Tijssen J, Onuma Y, Serruys P, Wykrzykowska J
July 20, 2018 | 10.4244/EIJ-D-17-01152

Latest news

EDITORIAL
A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…
June 11, 2021
NEW
Intracoronary OCT: State of the Art and Future Directions
Ziad A. Ali et al.
June 11, 2021
PCR Companion attending EuroPCR? Activate your free subscription!
May 28, 2021
TRIALS BOOK
Access the full Trials Book 2021
(Thanks to the support of Biotronik)
May 18, 2021
EDITORIAL
The Complex Relationship Between Geometrical and Functional Results of PCI
Nieves Gonzalo et al.
June 17, 2021
EDITORIAL
Fruitful New Data on Left Main PCI: the LEMON Study
Maria D. Radu Juul Jensen et al.
June 11, 2021
JAA
This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...
June 8, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke